pharmas

pharmas are investing heavily in research and development.

major pharmas have partnered to develop new cancer treatments.

the pharmas face increasing pressure to lower drug prices.

pharmas must comply with strict regulatory standards.

several pharmas have withdrawn their applications for approval.

pharmas conduct clinical trials to test new medications.

the pharmas announced record profits this quarter.

international pharmas compete for market dominance in asia.

pharmas lobby congress for favorable legislation.

generic pharmas provide affordable alternatives to brand-name drugs.

the pharmas signed a multi-billion dollar agreement.

pharmas prioritize fast-tracking essential medicines.